Skip to contentM
Mesa Laboratories Inc
M
MLABMesa Laboratories Inc Q1 2024 · 10-Q
Revenue$50.65M$50.65M+0.4% vs Q1 2023 Net Income-$549.00K-$549.00KN/M vs Q1 2023 EPS Diluted-$0.10-$0.10N/M vs Q1 2023 Gross Profit$31,183,000−0.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mesa Laboratories Inc · CIK 724004 · Engraved from SEC EDGAR
Operating Cash Flow$9,939,000N/M Free Cash Flowderived$9,669,000N/M Margins · derivedGross margin61.6%−0.5 pt vs Q1 2023
Operating margin-1.3%+7.8 pt vs Q1 2023
Net margin-1.1%+1.8 pt vs Q1 2023
ended Jun 30, 2023 · filed Aug 3, 2023 · 34 d after period end